Buzz for gene therapies is loud, but drugmakers struggle to get treatments off the ground

The current state of Roctavia, the first gene therapy for treating hemophilia A, and the struggles faced by drugmakers in the gene therapy market

Related Keywords

,Bloomberg ,Biomarin Pharmaceutical ,Roctavia ,Reating ,Hemophilia A ,Gene Therapy ,Inherited Disorders ,Commercial ,00 Million ,Drugmakers ,Most ,